These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25432720)

  • 61. Recent advances in the genetics of dementia with lewy bodies.
    Bonifati V
    Curr Neurol Neurosci Rep; 2008 May; 8(3):187-9. PubMed ID: 18541113
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report.
    Ceravolo R; Antonini A; Frosini D; De Iuliis A; Weis L; Cecchin D; Tosetti M; Bonuccelli U; Cosottini M
    Mov Disord; 2015 Jul; 30(8):1148-9. PubMed ID: 26095323
    [No Abstract]   [Full Text] [Related]  

  • 63. [Parkinson disease: genetics and neuronal death].
    Destée A; Mutez E; Kreisler A; Vanbesien-Maillot C; Chartier-Harlin MC
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F80-5. PubMed ID: 19593875
    [No Abstract]   [Full Text] [Related]  

  • 64. What causes cell death in Parkinson's disease?
    Gupta A; Dawson VL; Dawson TM
    Ann Neurol; 2008 Dec; 64 Suppl 2(0 2):S3-15. PubMed ID: 19127586
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic susceptibility in Parkinson's disease.
    Bras JM; Singleton A
    Biochim Biophys Acta; 2009 Jul; 1792(7):597-603. PubMed ID: 19063963
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic.
    Sardi SP; Cedarbaum JM; Brundin P
    Mov Disord; 2018 May; 33(5):684-696. PubMed ID: 29704272
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Parkinsonism, dementia and glucocerebrosidase mutations.
    Peall K; Robertson NP
    J Neurol; 2013 May; 260(5):1441-4. PubMed ID: 23620067
    [No Abstract]   [Full Text] [Related]  

  • 68. Parkinson disease.
    Balestrino R; Schapira AHV
    Eur J Neurol; 2020 Jan; 27(1):27-42. PubMed ID: 31631455
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the P
    Schlossmacher MG; Tomlinson JJ; Santos G; Shutinoski B; Brown EG; Manuel D; Mestre T
    Eur J Neurosci; 2017 Jan; 45(1):175-191. PubMed ID: 27859866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic causes of PD: A pathway to disease modification.
    Toffoli M; Vieira SRL; Schapira AHV
    Neuropharmacology; 2020 Jun; 170():108022. PubMed ID: 32119885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The genetics of Parkinson's disease.
    Mullin S; Schapira A
    Br Med Bull; 2015 Jun; 114(1):39-52. PubMed ID: 25995343
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structural variation and the expanding genomic architecture of Parkinson disease.
    Shulman JM
    JAMA Neurol; 2013 Nov; 70(11):1355-6. PubMed ID: 24018918
    [No Abstract]   [Full Text] [Related]  

  • 73. Neurodegeneration in Parkinson disease: moving Lewy bodies out of focus.
    Schulz-Schaeffer WJ
    Neurology; 2012 Dec; 79(24):2298-9. PubMed ID: 23152588
    [No Abstract]   [Full Text] [Related]  

  • 74. Genetic analysis of pathways to Parkinson disease.
    Hardy J
    Neuron; 2010 Oct; 68(2):201-6. PubMed ID: 20955928
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biomarkers for PD: How can we approach complexity?
    Berg D; Bandmann O
    Neurology; 2013 Feb; 80(7):608-9. PubMed ID: 23325899
    [No Abstract]   [Full Text] [Related]  

  • 76. Endonuclease-G and the pathways to dopaminergic neurodegeneration: a question of location?
    Hogg MC; Prehn JH
    EMBO J; 2013 Nov; 32(23):3014-6. PubMed ID: 24162725
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Caspase-1 clipping causes complications for α-synuclein.
    Nuber S; Selkoe DJ
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):9958-60. PubMed ID: 27551083
    [No Abstract]   [Full Text] [Related]  

  • 78. α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2.
    Wang S; Xu B; Liou LC; Ren Q; Huang S; Luo Y; Zhang Z; Witt SN
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16119-24. PubMed ID: 22988096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process.
    Karimi-Moghadam A; Charsouei S; Bell B; Jabalameli MR
    Cell Mol Neurobiol; 2018 Aug; 38(6):1153-1178. PubMed ID: 29700661
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred).
    Gwinn K; Devine MJ; Jin LW; Johnson J; Bird T; Muenter M; Waters C; Adler CH; Caselli R; Houlden H; Lopez G; Singleton A; Hardy J; Singleton A
    Mov Disord; 2011 Sep; 26(11):2134-6. PubMed ID: 21656851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.